EUVIMEDEUVIMED entdecken
Klinische Studie

An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color

Nour El-Kashlan, Ahuva Cices, Bridget Kaufman, Joel Correa Da Rosa, Ingrid Sanabria-Gonzalez, Saakshi Khattri, Andrew Alexis

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.7897 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Nour El-Kashlan und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Administration, Cutaneous, Dapsone, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisAdministration, CutaneousDapsoneSeverity of Illness IndexAdolescentAdultFemaleHumansMaleYoung AdultGelsHyperpigmentationQuality of LifeSkin PigmentationTreatment OutcomeEthnic and Racial Minorities

Substanzen

DapsoneGels

Zitieren

APA

El-Kashlan, N., Cices, A., Kaufman, B., Da Rosa, J. C., Sanabria-Gonzalez, I., Khattri, S., & Alexis, A. (2024). An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7897

Vancouver

El-Kashlan N, Cices A, Kaufman B, Da Rosa JC, Sanabria-Gonzalez I, Khattri S, et al. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7897

BibTeX
@article{ElKashlan2024,
  author = {El-Kashlan, Nour and Cices, Ahuva and Kaufman, Bridget and Da Rosa, Joel Correa and Sanabria-Gonzalez, Ingrid and Khattri, Saakshi and Alexis, Andrew},
  title = {An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.7897}
}
Kostenlos starten →